Nogi, Japan

Takashi Komine

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Komine. Retrieved from https://idiyas.com/inventor/takashi-komine-8grtxbvx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Komine: Innovator in AMPK Activator Research

Introduction

Takashi Komine is a prominent inventor based in Nogi-machi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of methods for screening AMPK activators. His innovative work has the potential to impact various therapeutic areas.

Latest Patents

Takashi Komine holds 1 patent related to an AMPK activator screening method. This patent describes a method for screening an AMPK activator, wherein the inhibition of an interaction between prohibitin and AMPK is used as an index. Additionally, the patent provides an AMPK activator that comprises, as an active ingredient, a compound inhibiting the interaction between prohibitin and AMPK, along with a prohibitin-AMPK complex.

Career Highlights

Komine is associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research. His work at this esteemed company has allowed him to focus on innovative solutions in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Tomohiro Ide and Naoki Kobayashi. Their collaboration has contributed to the success of various projects within the company.

Conclusion

Takashi Komine's contributions to the field of AMPK activator research highlight his role as an influential inventor. His innovative methods and collaborations continue to pave the way for advancements in biochemistry and pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…